UK Bioindustry Association (BIA) chief executive Steve Bates has given a lukewarm reaction to the government’s stance towards trade negotiations with the European Union and the USA.
In recent days, the British government set out its negotiating position for the UK’s future relationship with the EU, as well as its approach towards trade talks with Washington.
The UK says it is seeking “the type of agreement which the EU has already concluded in recent years with Canada and other friendly countries,” which would amount to a comprehensive free trade agreement based on zero tariffs and zero quotas.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze